Product Images Adakveo
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Adakveo NDC 0078-0883 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Preparation and Administration - seg101 01
This text seems to be a formula for calculating the volume of a medication called ADAKVEO based on the patient's body weight and prescribed dose. However, some characters are unreadable making the formula incomplete and its functionality not available.*
PRINCIPAL DISPLAY PANEL NDC 0078-0883-61 Rx Only ADAKVEO® (crizanlizumab-tmca) Injection 100 mg/10 mL (10 mg/mL) For intravenous infusion after dilution. 1 Single-Dose Vial. Discard Unused Portion. NOVARTIS - seg101 02
ADAKVEO is an injection medication used for intravenous infusion after dilution. Each 10 mL vial contains 100 mg of crizanlizumab-tmca, citric acid, poloxamer 188, sodium citrate, sucrose, and water for injection. Before using the injection, ensure that there is no acceleration or particular matter. It is recommended to store and transport the vial refrigerated at 2°C to 8°C (36°F to 46°F) while protected from light. For more information, please visit their website or call as indicated.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.